Literature DB >> 22198219

Reversal of neuromuscular blockade with sugammadex in a patient with spinal muscular atrophy type III (Kugelberg-Welander syndrome).

Hugo Vilela, João Santos, João Colaço, Eduardo Oliveira, Pedro Canas-da-Silva.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22198219     DOI： 10.1007/s00540-011-1308-z

Source DB:  PubMed          Journal:  J Anesth        ISSN： 0913-8668            Impact factor:   2.078


× No keyword cloud information.
  5 in total

1.  Safety and efficacy of sugammadex for the reversal of rocuronium-induced neuromuscular blockade in cardiac patients undergoing noncardiac surgery.

Authors:  Vegard Dahl; Philippe E Pendeville; Markus W Hollmann; Tom Heier; Esther Am Abels; Manfred Blobner
Journal:  Eur J Anaesthesiol       Date:  2009-10       Impact factor: 4.330

2.  Anaesthesia for caesarean section in spinal muscular atrophy type III.

Authors:  L McLoughlin; P Bhagvat
Journal:  Int J Obstet Anesth       Date:  2004-07       Impact factor: 2.603

Review 3.  The undesirable effects of neuromuscular blocking drugs.

Authors:  C Claudius; L H Garvey; J Viby-Mogensen
Journal:  Anaesthesia       Date:  2009-03       Impact factor: 6.955

4.  Anaesthesia for caesarean section in a patient with spinal muscular atrophy.

Authors:  A U Buettner
Journal:  Anaesth Intensive Care       Date:  2003-02       Impact factor: 1.669

5.  The use of sugammadex in a patient with myasthenia gravis.

Authors:  C Unterbuchner; H Fink; M Blobner
Journal:  Anaesthesia       Date:  2010-01-23       Impact factor: 6.955
  5 in total
  3 in total

Review 1.  Cardiac pathology in spinal muscular atrophy: a systematic review.

Authors:  C A Wijngaarde; A C Blank; M Stam; R I Wadman; L H van den Berg; W L van der Pol
Journal:  Orphanet J Rare Dis       Date:  2017-04-11       Impact factor: 4.123

Review 2.  Sugammadex as a reversal agent for neuromuscular block: an evidence-based review.

Authors:  Stefan Josef Schaller; Heidrun Fink
Journal:  Core Evid       Date:  2013-09-25

3.  Use of sugammadex in patients with neuromuscular disorders: a systematic review of case reports.

Authors:  Usha Gurunathan; Shakeel Meeran Kunju; Lisa May Lin Stanton
Journal:  BMC Anesthesiol       Date:  2019-11-19       Impact factor: 2.217
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.